Next Article in Journal
ZEB1/miR-200c/AGR2: A New Regulatory Loop Modulating the Epithelial-Mesenchymal Transition in Lung Adenocarcinomas
Previous Article in Journal
Ubiquitylation-Mediated Fine-Tuning of DNA Double-Strand Break Repair
Article

Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations

1
Department of Health Sciences, Center for Applied Genetics and Genomic Medicine, University of Arizona, Tucson, AZ 85721, USA
2
Arizona Research Labs, University of Arizona Genetics Core, University of Arizona, Tucson, AZ 85721, USA
3
Department of Medicine, Division of Hematology and Oncology, University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA
4
Department of Medicine—Hematology/Oncology, University of Texas Health San Antonio, Mays Cancer Center, San Antonio, TX 78229, USA
*
Authors to whom correspondence should be addressed.
Cancers 2020, 12(6), 1618; https://doi.org/10.3390/cancers12061618
Received: 12 May 2020 / Revised: 5 June 2020 / Accepted: 9 June 2020 / Published: 18 June 2020
Whole exome sequencing (WES) of matched tumor-normal pairs in rare tumors has the potential to identify genome-wide mutations and copy number alterations (CNAs). We evaluated 27 rare cancer patients with tumor-normal matching by WES and tumor-only next generation sequencing (NGS) as a comparator. Our goal was to: 1) identify known and novel variants and CNAs in rare cancers with comparison to common cancers; 2) examine differences between germline and somatic variants and how that functionally impacts rare tumors; 3) detect and characterize alleles in biologically relevant genes-pathways that may be of clinical importance but not represented in classical cancer genes. We identified 3343 germline single nucleotide variants (SNVs) and small indel variants—1670 in oncogenes and 1673 in tumor suppressor genes—generating an average of 124 germline variants/case. The number of somatic SNVs and small indels detected in all cases was 523:306 in oncogenes and 217 in tumor suppressor genes. Of the germline variants, six were identified to be pathogenic or likely pathogenic. In the 27 analyzed rare cancer cases, CNAs are variable depending on tumor type, germline pathogenic variants are more common. Cell fate pathway mutations (e.g., Hippo, Notch, Wnt) dominate pathogenesis and double hit (mutation + CNV) represent ~18% cases. View Full-Text
Keywords: rare tumors; whole exome sequencing; tumor-germline matched sequencing; inherited variants; copy number alteration (CNA); double hits rare tumors; whole exome sequencing; tumor-germline matched sequencing; inherited variants; copy number alteration (CNA); double hits
Show Figures

Graphical abstract

MDPI and ACS Style

Sprissler, R.; Perkins, B.; Johnstone, L.; Babiker, H.M.; Chalasani, P.; Lau, B.; Hammer, M.; Mahadevan, D. Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations. Cancers 2020, 12, 1618. https://doi.org/10.3390/cancers12061618

AMA Style

Sprissler R, Perkins B, Johnstone L, Babiker HM, Chalasani P, Lau B, Hammer M, Mahadevan D. Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations. Cancers. 2020; 12(6):1618. https://doi.org/10.3390/cancers12061618

Chicago/Turabian Style

Sprissler, Ryan, Bryce Perkins, Laurel Johnstone, Hani M. Babiker, Pavani Chalasani, Branden Lau, Michael Hammer, and Daruka Mahadevan. 2020. "Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations" Cancers 12, no. 6: 1618. https://doi.org/10.3390/cancers12061618

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop